To further examine the role of FAK in TNFRSF14 signaling, we applied a specific FAK Y397 phosphorylation inhibitor, Defactinib, to investigate whether FAK Y397 phosphorylation is involved in TNFRSF14-mediated malignant behavior regulation in GBM cells [23]. The gene discussed is PTK2; the disease is glioblastoma.